Cuspis Capital II Ltd. and Cytophage Technologies Inc. Enter into Letter Of Intent for Qualifying Transaction
Toronto, Ontario – TheNewswire – February 17, 2022 – Cuspis Capital II Ltd. (TSXV:CCII.P) (“Cuspis” or the “Corporation”), a capital pool company as defined under TSX Venture Exchange (“TSXV” or […]